Edgen Stock·Nov 25 2025, 09:28Back
European Commission Approves Sanofi and Regeneron's Dupixent for Chronic Spontaneous Urticaria
Edgen Stock·Nov 25 2025, 09:28
[1] DUPIXENT® (dupilumab) for Chronic Spontaneous Urticaria (CSU ... (https://www.dupixenthcp.com/chronic-spontaneo ...)[2] Dupixent® (dupilumab) Approved as the First Targeted (https://www.globenewswire.com/news-release/20 ...)[3] CHMP recommends Sanofi and Regeneron's Dupixent to treat ... (https://manufacturingchemist.com/chmp-recomme ...)
